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Introduction: Non-invasive ventilation (NIV) is not proven to be effective in treating respiratory failure in
severe pneumonia. However, some clinicians nevertheless attempt NIV to indirectly deliver adequate
oxygenation and avoid unnecessary endotracheal intubation.
Case presentation: In this article, we report the case of a 24-year-old woman at 32 weeks' gestation who
presented with hypoxemic respiratory failure requiring mechanical ventilation. She was successfully
managed by NIV.
Discussion: However, NIV must be managed by providers who are trained in mechanical ventilation. This
is of the utmost importance in avoiding any delay should the patient's condition worsen and require
endotracheal intubation. Moreover, in pregnant women, the severity of illness may progress quickly due
to the immunosuppression inherent in these patients.
Conclusion: Special attention should be given to the choices of invasive ventilation and NIV to manage
community acquired pneumonia patients in third trimester.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
This case report is focused on Non-invasive ventilation (NIV) in
acute hypoxemic respiratory failure secondary to pneumonia in
pregnant women (third trimester). Pneumonia in pregnancy is
associated with morbidity and mortality to the fetus and mother.
The risk of intubation is higher in pregnant womenwith hypoxemic
respiratory failure compared to non-pregnant women. Pregnant
women with pneumonia may develop worse hypoxemic respira-
tory failure due to the physiological changes that occur during
pregnancy. Physiological changes such as increased progesterone
lead to mucosal airway edema. The mechanical effects of an
enlarged uterus result in a reduced functional residual capacity
(FRC). Decreased esophageal sphincter tone, delayed gastric
emptying, and increased gastric pressure (as early as 14 weeks and
above) increase the risk of gastric aspiration during NIV. The risk of
aspiration is 1 in 10,000. Therefore, NIV is only indicated insiology and Intensive Care,
rsiti Sains Malaysia, 16150,
Ltd. This is an open access article upregnant women who are fully conscious and able to control their
airway with adequate respiratory effort. It is contraindicated in
hemodynamically unstable patients. Prompt diagnosis and
aggressive monitoring and treatment in an Intensive Care Unit
(ICU) are required for better outcome of the fetus and mother [1]. A
trial of NIV may have a beneﬁt to treat hypoxemic respiratory
failure, provided it is used wisely. It is reported that NIV can avoid
intubation in 54% of acute respiratory distress (ARDS) and therefore
reduce ventilator associated pneumonia (VAP) by approximately
20% and reduce the mortality rate in the ICU by up to 54% [2].
However, the usage of NIV has remained controversial in severe
pneumonia. The beneﬁt of NIV in pregnant women is not clear.
However, Masclans et al. reported that the success rate of NIV was
as high as 40% in treating hypoxemic respiratory failure due to
pneumonia [3]. A proper patient selection, a cooperative patient,
and clinician skills are the key features of successful NIV. The trend
of using NIV has increased by approximately 25% [3]. The per-
centage of patients receiving non-invasive ventilation in Malaysia
increased almost six-fold between 2004 and 2012, from 3.7% to
21.7%. Therefore, the usage of NIV in the non-pregnant population
secondary to pneumonia is controversial but is becoming increas-
ingly acceptable.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Normal chest X-Ray.
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A 24-year-old Asian woman at 32 weeks' gestation presented
with a 2-day history of worsening dyspnea. She gave a history of
sore throat, dry cough, fever, nausea, vomiting, myalgia, weakness
and headache. Her examination revealed reduced air entry on both
lower zones of the lung with crepitation on auscultation. The rest of
the examination was unremarkable. Arterial blood gases (ABG)
showed severe hypoxemia with po2 only 90 mmHg despite de-
livery of ﬁo2 70% via NIV. She had an elevated C-reactive protein
(CRP) 200 mg/L on admission. Her chest radiograph demonstrated
bilateral opacities consistent with severe pneumonia (Fig. 2) in
comparison with her normal chest radiograph taken 2 years prior
to illness (Fig. 1). Her tracheal aspirate and urine culture were
negative. There were also negative results for nasopharyngeal swab
for H1N1. She also tested negative for dengue, infectious diseases
such as tuberculosis, human immunodeﬁciency virus (HIV), hepa-
titis and syphilis. She was admitted to our ICU and was started on
non-invasive ventilation (NIV) bi-level mode. Her condition grad-
ually worsened within a day of admission. She was given intrave-
nous rehydration and broad spectrum antibiotics, tazocin 4.5 g
every 6 hours and levoﬂoxacin 750 mg once daily and antiviral
osetalmivir. She was planned for intubation if her dyspnea wors-
ened, her respiratory rate increased to more than 35 breaths per
minute, or there was a drop in consciousness level. The patient was
started on a BiPAP, bi-level positive airway pressure (Philips-
Respironics) after poor oxygenation with a high ﬂow mask 15 liters
oxygen. She was successfully weaned from NIV on day 3 of venti-
lation. She was discharged from the ICU to the general ward on day
5 and discharged home on day 13 of admission in good condition.
Fig. 2 (a). Patchy air space opaciﬁcation of the bilateral mid and
lower zone with the presence of air bronchogram consistent with
consolidation with associated bilateral pleural effusion on the dayFig. 2. Chest X-Ray of aof admission to the ICU. Fig. (2b) shows worsening of the bron-
chogram on Day 2. Fig. (2c) shows resolving consolidation and
pleural effusion on Day 4.
3. Discussion
Mechanical ventilation in pregnancy is not without risk. The
main indications for NIV are to provide adequate oxygenation and
to avoid the complications of intubation. Prolonged hypoxia results
in increased fetal morbidity and mortality. In cases of severe res-
piratory failure during pregnancy, there is a risk of preterm delivery
of up to 80% during the third trimester and a risk of spontaneous
miscarriage of up to 57% during the ﬁrst trimester [4]. To ensure
patient safety, these patients should be managed and monitored
closely in an ICU with a trial of NIV [5].
Hemodynamic instability, impaired consciousness, and wors-
ening type 1 respiratory failure with tachypnea greater than 35
breaths per minute are clinical signs that these patients need to be
intubated. In cases similar to our own, Banga et al. managed
pregnant women with severe type 1 respiratory failure secondary
to pneumonia with 3e4 days of NIV. In these cases, major organ
dysfunction and impaired consciousness were the key factors un-
derlying the decision to institute NIV [6]. NIV is contraindicated in
the setting of cardiac or respiratory arrest and in cases where the
patient is uncooperative or unable to ﬁt the mask [7]. It is also
unsuitable for patients who are status post facial, esophageal or
gastric surgery; patients with extreme anxiety, copious secretions,
anatomical anomalies of the upper airway, or craniofacial trauma or
burns. NIV should also be avoided in patients with a high risk of
aspiration and patients who are unable to protect their airway. In
these situations, the use of NIV has a failure rate as high as 50% in
patients with hypoxemia [7].
A study demonstrated NIV is proven to be effective only in pa-
tients with cardiogenic pulmonary edema and chronic obstructive
airway disease [7]. NIV should be considered ﬁrst line therapy early
in the course of respiratory failure secondary to either of the above
conditions. Studies have shown that in chronic obstructive pul-
monary disease (COPD) patients, the use of NIV can decrease
mortality by 48%, decrease the rate of intubation by 59% and
decrease hospital length of stay by 3.24 days [8]. However, it can
also be used to treat other disorders such as pneumonia in an
immunocompromised patient, post-operative respiratory failure,
hypoxemic respiratory failure, acute respiratory distress syndrome
(ARDS), and asthma. NIV can also be employed to facilitate venti-
lation weaning and extubation.
In our case, the cause of the patient's worsening hypoxemic
respiratory failure was community acquired pneumonia assevere pneumonia.
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c-reactive protein level (>200 mg/dl) and chest radiograph ﬁnd-
ings. The CURB-65 score for our patient was only 1. The sequential
organ failure assessment (SOFA) score was 4. The patient was
admitted to the ICU for a trial of NIV even though its beneﬁt in
pneumonia has not been proven. However, trials of NIV can be used
before resorting to tracheal intubation as long as the patient re-
mains conscious, tolerates a tight-ﬁtting mask, and does not
become lethargic. However, it must be used sagaciously in a well-
monitored ICU.
The step taken in our case was to explain the procedure and its
beneﬁt to the patient in detail. The possible need for intubation
should NIV therapy fail within the ﬁrst 2 hours of use was also
explained. Choosing the correct interface, starting with a very low
inspiratory positive airway pressure (IPAP) setting of 6e8 cm H2O
and setting an expiratory positive airway pressure (EPAP) of 2e4
cm H2O are the key features of successful NIV. The setting can be
increased gradually to achieve the desired oxygenation. The dif-
ference between IPAP and EPAP should be at least 4 cmH2O. Next,
the oxygen requirement was set up followed by holding the mask
over the face by hand. Initially, it should not be ﬁxed. If required,
EPAP and IPAP settings can be increased in 1e2 cmH2O increments,
after which the inspiratory time and rise time should be set. Lastly,
the interface was secured to the patient with head straps to avoid
excessive air leak [7]. Excessive tightness should be avoided since it
can cause intolerance and skin lesions [7].
Arterial blood gases should be taken hourly during ﬁrst 2 hours
bi-level NIV therapy. If the arterial blood gases show worsening
respiratory failure with tachypnea greater than 35 breaths per
minute, the patient should be intubated immediately to prevent
prolonged hypoxia in the fetus.
Even though a chest radiograph showed worsening pulmonary
inﬁltrates on day 2 of admission, the patient was not intubated
because she remained conscious and her respiratory rate (RR)
remained between 30 and 35 breaths per minute with good res-
piratory effort. An improvement in RR was found to be predictor of
successful NIV [9]. At that time, the bi-level NIV setting was 12 IPAP
and 8 EPAP with ﬁo2 of 70%. The PaO2/FiO 2 was less than 100.
Given the patient's worsening condition, she was kept nil bymouth
on day 2 of admission. The patient was given intravenous ﬂuid as
normal saline 1500 ml over 24 hours for two days. The ﬂuid was
given in view of worsening lactate, low concentrated urine output
and capillary reﬁll time less than 2 seconds. On day 3 of admission,
the ﬂuid was stopped because of suddenly worsening pulmonary
inﬁltrates. Bedside echocardiography was conducted and revealed
good heart function. A tracheal aspirates culture result came back
as mixed growth. Serial C - reactive protein results showed a
decreasing trend. On day 4 of admission, the patient showed signs
and symptoms of improvement as evidenced by reduced tachypnea
maintained with lower bi-level settings. The patient then was
transferred to the general ward and discharged home on day 10
after completing an intravenous antibiotic course. At 38 weeks, thepatient vaginally delivered a healthy baby without complication.4. Conclusion
NIV can be used in a pregnancy complicated by severe hypox-
emic respiratory failure secondary to community acquired pneu-
monia with a CURB-65 score of 1 and a sequential organ failure
assessment (SOFA) score of 4. However, the usage of NIV must be
judiciously monitored and reviewed in an ICU during the initial
phases of non-invasive bi-level ventilation.Conﬂicts of interest
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